TECH TRANSFER University Joins Industry. Maite Aguado Pharmaceutical Technology PL Synthon Hispania

Similar documents
Q8 and Q8 annex An industry Perspective

Quality by Design. Innovate Design Development Create value. Correct definition of QbD and its relation to product and process development

Analytical Methods and Sampling in the New Manufacturing Paradigm a Regulatory Perspective

PMDA perspective on Quality by Design for pharmaceutical products

Implementation of ICH Q8 and QbD An FDA Perspective

Challenges of Implementation of ICH Q 8

Value Paper. Are you PAT and QbD Ready? Get up to speed

EU GMP Evolution or Revolution Scope and drivers for EU GMP changes. August Gordon Farquharson

peace of mind For from development to commercial supply

Importance of ICH Guidance in Fulfilling Process Validation Requirements

Leader in Pharmaceutical Films

CMC Topics and PMDA s activities Yoshihiro Matsuda, Ph.D.

Application of Visible-Residue Limit for Cleaning Validation Richard J. Forsyth and Vincent Van Nostrand By Richard J. Forsyth,Vincent Van Nostrand

JUST SCRATCHING THE SERVICE

STRATEGIES FOR SUCCESSFUL SCALE-UP USING QUALITY BY DESIGN

PROCESS ANALYTICAL TECHNOLOGY (PAT) - AS A CULTURE OF INNOVATION

Implementing Quality Systems

Global GMP Harmonisation A Japanese Perspective

EDQM Conference. Quality of Medicines in a Globalised World: Dreams and Reality

Technology Transfer Plays an Increasingly Important Role in Pharmaceutical Quality Systems

From API to Formulated Product

Feedback EMEA / Industry Discussion

Quality by Design, Clinical Relevance & Lifecycle Considerations

Timescales for Change A Look at Innovation in the Pharmaceutical Industry

MAH Responsibilities including the Management of CMOs. QP Forum Workshop. Robert Byrne and Eoin Duff Quality Assurance Alexion Pharmaceuticals

Pharmaceutical Manufacturing and Engineering Catalog Excerpt

Glatt Technology Center

APIs global business developments

Quality by Design and OINDP. Today s Presentation

ICH Q8 / ICH Q11 Training Course

API hapis High Potency Active Pharmaceutical Ingredients. High Potency Active Pharmaceutical Ingredients. Innovation made. Easy.

Pharmaceutical Process Development

Section heading. Strapline sub-heading

Terrence Tougas. Dennis Sandell

International Journal of Pharma and Bio Sciences PROCESS ANALYTICAL TECHNOLOGY IMPLEMENTATION- PROGRESSION FOR A PHARMACEUTICAL INDUSTRY ABSTRACT

Embracing Quality by Design. Applying QbD concepts can help CMOs create value

Innovative Approaches to Pharmaceutical Development and Manufacturing Seminar Series

Future of Pharmaceutical Quality and the Path to Get There

QbD/PAT Implementation: The Road to RTR From Science to Compliance

ConsiGma TM, a platform for continuous processing

ICH Q8, 9 & 10 and the Impact on the QP

The Changing Face of Product and Process Development in the QbD Era. James Kraunsoe AstraZeneca Product Development UK/US

Process Analytical Technology (PAT): A Real Time Quality Assurance

How Process Models can Facilitate Quality Risk Management for Emerging Technologies

the SPD company Dr Clive Simon, Principal, The SPD Company.

QbD Application in Japan: PMDA Perspective

Artwork Lifecycle Process Management. Vilva Natarajan CEO, Karomi

WHITE PAPER FACILITY FOCUS: GMP Facility Modernization. By: David M. Marks, P.E.

Symposium on Continuous Manufacturing of Pharmaceuticals Notes

VisioNIR. High Speed NIR Spectrometer for 100% Process Inspection

Glatt Technology Center

The GEA Pharma Solids Center. Improving your products, optimizing your processes, making science work

ICH Q12 (Pharmaceutical Product Lifecycle Management): PMDA Perspective

Technical Specifications: Supply of Seamless Grade TP304L Pipe and Grade WP304L Pipework Fittings to the ITER Organization (IO).

QUALITY: BRACKETING AND MATRIXING DESIGNS FOR STABILITY TESTING OF NEW VETERINARY DRUG SUBSTANCES AND MEDICINAL PRODUCTS

Quality Regulation under Revised Pharmaceutical Affair Law

2008 Course Programs Schedule

Claudio Pincus, President, The Quantic Group R. Owen Richards, President, Quantic Regulatory Services Daniel Pincus, Consultant, The Quantic Group

Quality Risk Management

Technically Unavoidable Particles Profile (TUPPs) Guide

Introduction. Methods: Spherical Granulation. Shawn Engels, Vector Corporation

CDER s Office of Pharmaceutical Quality (OPQ): Delivering on the 21 st Century Quality Goals

Technology Transfer as the Process of Pharmaceutical Quality System: Modelling Technology Transfer as a Process Strategy

Combination Products Verification, Validation & Human Factors Sept. 12, 2017

CLICK TO ADD TITLE [SPEAKERS NAMES]

International Conference on Pharmaceutical Research and Development June 06-07, 2018 Philadelphia, USA

Bosch Packaging Academy Seminars & Workshops

Introduction to STP (Clinical Science) Clinical Pharmaceutical Sciences

How CDER is Encouraging Adoption of Emerging Technologies in Pharmaceutical Industry

ICH Q10 Pharmaceutical Quality System

DSM Sinochem Pharmaceuticals

Brazilian industry s activities for international convergence. Walker Lahmann Director of External Trade at ABIFINA Executive Director at Eurofarma

Training. Education CALENDAR FEDEGARI TECH CENTERS DM#407036

Manufacture of medicinal products in Italy: challenges for the Italian Medicines Agency

Workshop: GRANULATION & TABLETING New requirements for an established technology - robustness, efficiency and quality.

Claus Mortensen, Medicines Inspector. Danish Medicines Agency. Member of the EMEA PAT team

WHITE PAPER FACILITY FOCUS: Next Generation Aseptic Manufacturing: An Eye-Opening Peek into the Future. By: Hite Baker

Technology transfer in pharmaceutical industry- A Review

Presentation. March 2007

Impact of ICH Q9 and the application of Risk Management

EXCIPIENTS KNOWLEDGE MANAGEMENT: CHALLENGES & SOLUTIONS

Local Production of Pharmaceuticals and Related Technology Transfer UNCTAD/CD-TFT 1. Background

Microcrystalline Wax and Wax Blends. Absolute Purity.

Quality assurance in the supply chain for pharmaceuticals from the WHO perspective

Pharmaceutical Products and Services

World Journal of Pharmaceutical Research SJIF Impact Factor 7.523

Sectoral Patterns of Technical Change

Technology to meet the needs of patients around the world

Speed Innovation Happiness. Corporate Overview

Granulation & Tableting

Leveraging Med Device Expertise to Develop Combination Products

Master Data Management: Building readiness for regulations Compliance can benefit, but so can internal speed and efficiency

Factors that should be considered when selecting and sizing a mixer are:

Submission of comments on Review of the Variations Guidelines (EC 1234/2008)

How to take advantage of China knowledge base?

Innovative technologies for powder processing

TOP INDUSTRY EXPERTS IN ONE TRAINING EVENT!

ISPE India in collaboration with

ICH Q7 - API. Presented by Ashley Isbel 4 July, 2016

CORE EXPERTISE IN YOUR TECHNOLOGIES

Transcription:

TECH TRANSFER University Joins Industry Maite Aguado Pharmaceutical Technology PL Synthon Hispania

About me.. - Chemical Degree (UAB) / Master In Pharmaceuticals and Related Products(IUCT) / Master In Project Management (La Salle)/Different trainings trough my professional experience - Working in Pharma industry for nearly 20 years: (IUCT/ Sanofi- Aventis/Combino Pharm/ Synthon) - Experience on Formulation Development, Scale up and Pilot Plant and Commercial processes. Date Tech Transfer - University Joins Industry 2

INDEX - What is Tech Transfer? - Tasks and Responsibilities - Background, key points and basic knowledge in - Technical Evaluation - Personal Skills - Career development Date Tech Transfer - University Joins Industry 3

What is Tech Transfer? Definition: is the process of transferring technology from the places and in groups of its origination to wider distribution among more people and places What does this means? üdeeply Knowledge of the Product and Process and Persons ütransfer of Knowledge to internal and external people ütransfer of processes: to internal and external plants Where does our responsibilities start? Tech Transfer R&D Development Scale up Pilot Plant Commercial Main Plant Prototype Trials Q batches S- batches Transfer Validation Commercial Date Tech Transfer - University Joins Industry 4

Tasks and Responsibilities First.understand with whom we are involved Maintenance QC QA Manufacturing Project Management Packaging Technology Suppliers TECH Group Supply Chain CMO Finnance Customers Purchase RA R&D Date Tech Transfer - University Joins Industry 5

And then. what are our tasks???? ØTransfers (New or already commercial): ümanufacturing Processes Transfer Launch: from the Pilot Plant to a Main Plant (Internal or external) Between Plants Scale up ü Packaging ØProcess Optimization: üreduce Costs, Times, Operational procedures üquality improvements o process variability ØTroubleshooting üsolve problems.as fast as you can!!!!!!! (Internal or External) üimprovements to avoid quality recurrences Date Tech Transfer - University Joins Industry 6

And then. what are our tasks???? Ø Others: üevaluation of manufacturing processes still on R&D phase ürevision of Submission Dossiers üinvestigate Deviations übe involve in Health Authorities and Customers Audits üevaluate new excipients or drug substance suppliers üevaluation of new CMO s, new equipments, new technologies ütechnical support in the regulatory submissions ütechnical support to Engineering, maintenance, QC,QA, manufacturing üevaluation of costs (validations, process costs..) üproduct Surveillance / Trend Analysis (continued process monitoring, APR s revision..) ütrainings We are the definitition of..multitasking!!!!!!!!!!!! Date Tech Transfer - University Joins Industry 7

Background, key points and basic knowledge Our maximum commandment: manufacturing products with the required quality. But always taking into account costs, time and flexibility. What we have to know to be excellent???? vthe product: Formulation: physical and chemical characteristics of excipients and drug substance; percentages, special requirements (sensible to the humidity/light..) Product development. Evaluation of the development in the R&D stages Final product specifications vthe process: Facilities Equipments: main equipments and auxiliary (ex. Pumps, tubs ) People!!!!!!!! Date Tech Transfer - University Joins Industry 8

Background, key points and basic knowledge vsubmitted dossiers What are the phases, equipments or settings approved? Type of product: standard, non standard Types of variation involved. What is needed to change the batch size, manufacturing site, equipment, settings. Countries????? vquality requirements: GMP, FDA, JPN????? vip patents. Can I change the excipient grade? Or change a setting or a manufacturing step? WE HAVE TO KNOW ALL ABOUT OUR PRODUCT, PROCESS,QUALITY, MARKET AND CLIENTS EXPECTATIONS. AND WITH ALL THIS INFORMATION WE PERFORM THE ASSESSMENT Date Tech Transfer - University Joins Industry 9

Technical Evaluation Once the previous evaluation is completed, the materials, process parameters and quality attributes are listed, categorized (critical or non critical) and related to each other. Materials Process Product (Critical) Material Attributes (Critical) Process Parameters (Critical) Quality Attributes Example: Granulation in a High Shear Mixer. Operation unit Materials Process parameters Quality attributes affected Granulation API Lactose Povidone Water Mixing Time Impeller speed Solution Addition time. Process time Dissolution/ Disintegration Uniformity of dosage units Assay Date Tech Transfer - University Joins Industry 10

Technical Evaluation According to the previous study, the risks are categorized and the mitigation actions are planned. Operation Unit Granulation CPP Risk CQA affected Mitigation Risk Mixing Time and speed High Assay Blend Uniformity Granulate Addition Medium Dissolution Disintegration Control of Torque Date Tech Transfer - University Joins Industry 11

Technical Evaluation When all the manufacturing steps, attributes and materials have been evaluated then.we evaluate the type of final study that we need: ØWe need to perform Trials for a better evaluation? For example when we have to transfer a manufacturing process between sites but we have non similar equipments ØQualification batch. We buy a new machine but it is equal to the previous used for the manufacturing and the risk is low. We made only one batch. ØValidation. Changes with high impact. For example. Transfers between sites, batch size increase. Than we have to chose the type of validation and how many batches are involved. ütraditional process validation: batches, complete validation ücontinuous process verification: CQAs and CPPs (when the R&D applies Quality by Design) ühybrid approach Traditional validation+ Continuous Process Verification Date Tech Transfer - University Joins Industry 12

Skills - Degree in Life Sciences - English But Also.. - Optimistic, curious, able to learn everyday - Multi-task, capable to work under pressure - Pragmatism - Resilient - Capable of making decisions - Open minded, emphatic - Work in group - Like to travel Date Tech Transfer - University Joins Industry 13

Career Development Manufacturing Quality Assurance TECH R&D Project Management Date Tech Transfer - University Joins Industry 14

Questions? THANKS FOR YOUR ATTENTION!!! Date Tech Transfer - University Joins Industry 15